Showing results (1391-1400 of 1,522) with videos related to
Sort By:
Pageof 153
Gene|January 17, 2017
X-linked elliptocytosis with impaired growth is related to mutated AMMECR1Lina Basel-Vanagaite, Nir Pillar, Ofer Isakov, et al.Journal of Molecular Histology|February 24, 2007
Practical aspects of planning, building, and interpreting tissue microarrays: the Cooperative Prostate Cancer Tissue Resource experienceA Kajdacsy-Balla, J M Geynisman, V Macias, et al.Journal of Health Communication|July 3, 2019
The Salzburg Statement on Vaccination AcceptanceScott C Ratzan, Barry R Bloom, Ayman El-Mohandes, et al.American Journal of Respiratory and Critical Care Medicine|June 12, 2018
Azithromycin for Early Pseudomonas Infection in Cystic Fibrosis. The OPTIMIZE Randomized TrialNicole Mayer-Hamblett, George Retsch-Bogart, Margaret Kloster, et al.The Journal of Infectious Diseases|June 3, 2000
Evaluation of lymph node virus burden in human immunodeficiency virus-infected patients receiving efavirenz-based protease inhibitor--sparing highly active antiretroviral therapyM Dybul, T W Chun, D J Ward, et al.Pediatrics|October 12, 2011
Multicomponent interventions to enhance influenza vaccine delivery to adolescentsLisa M Gargano, Karen Pazol, Jessica M Sales, et al.Scientific Reports|December 1, 2023
COVID-19 outcome is not affected by anti-CD20 or high-titer convalescent plasma in immunosuppressed patientsMary J Kasten, Brian D Lahr, Anusha Parisapogu, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|August 5, 2017
Sexual and reproductive health behaviors and experiences reported by young women with cystic fibrosisTraci M Kazmerski, Gregory S Sawicki, Elizabeth Miller, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 4, 2017
Sexual and reproductive health care utilization and preferences reported by young women with cystic fibrosisTraci M Kazmerski, Gregory S Sawicki, Elizabeth Miller, et al.The Lancet. HIV|September 15, 2025
Safety, tolerability, and immunogenicity of an adult-specific pneumococcal conjugate vaccine, V116, in people living with HIV (STRIDE-7): a two-part, parallel-group, randomised, active comparator-controlled, international, phase 3 trialJayani Pathirana, Moti Ramgopal, Charlotte Martin, et al.Pageof 153